R. Lis

Profiling the tumor microenvironment proteome in prostate cancer using laser capture microdissection coupled to LC⿿MS⿿A technical report

M. Loda, M. Bowden, C. Tonry, 2015, EuPA open proteomics.

Prostate cancer reactivates developmental epigenomic programs during metastatic progression

Henry W. Long, Keegan D. Korthauer, H. G. van der Poel, 2020, Nature Genetics.

The Proliferative Activity of Mammary Epithelial Cells in Normal Tissue Predicts Breast Cancer Risk in Premenopausal Women.

M. Loda, R. Tamimi, W. Barry, 2016, Cancer research.

Abiraterone Treatment in Castration-Resistant Prostate Cancer Selects for Progesterone Responsive Mutant Androgen Receptors

M. Loda, P. Kantoff, P. Nelson, 2014, Clinical Cancer Research.

A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer

M. Loda, W. Gerald, J. Clohessy, 2013, Nature Genetics.

SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression

Gerald C. Chu, T. Golub, L. Chin, 2011, Nature.